About ERN LUNG
Expertise
patients
clinicians
ERN-LUNG Academy

The ERN-LUNG Academy is a curriculum for medical staff at any stage of their career, who wishes to get a proof of knowledge on rare respiratory diseases. It consists of Webinars and eCases, but also includes on-site training in ERN-LUNG Centers. We call for applications from participants of EU-member States from September to November each year. Classes start in January. If you wish to apply for next yearโ€™s class, please send a letter of motivation to info@ern-lung.eu

ERN-LUNG Online advance system

The EXpert Advisory BOard (EXABO) is a pan-European internet platform, which has been developed in the context of ERN-LUNG in liaison with the Medical Informatics Group of University Hospital Frankfurt, to answer questions on all aspects of rare respiratory diseases. The platform is primarily aimed at patients and care team members but is openly accessible by anyone who wants to ask a related question.

NETWORK
News

Conference on Rare diseases and the European Reference Networks (10-11 October)

DATE:ย  10 Oct 2023 – 11 Oct 2023
TIME: All Day
Conference on Rare diseases and the European Reference Networks

The conference onย Rare diseases and European reference networksย will be organised under the auspices of the Spanish Presidency of the EU Council and in cooperation with the authorities of the Basque Country. It will take place on 10-11 October 2023 in the Euskalduna Conference Centre in Bilbao, Spain, with the participation of the following high-level speakers:

  • Gotzone Sagardui, Minister of Health of the Basque Government
  • Josรฉ Manuel Miรฑones Conde, Minister for Health of Spain
  • Stella Kyriakides, EU Commissioner for Health and Food Safety
  • Oliver Rรถpke, President of the European Economic and Social Committee

Rare diseases are conditions that are usually chronic and sometimes disabling or life-threatening. Approximately 7 000 rare diseases have been described, affecting 8% of the EU population (up to 36 million people). They severely undermine people’s health and quality of life and up to 95% of them have no specific treatment or cure options.